Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol
Completed · Early Phase 1
Conditions studied: End Stage Cardiac Failure, Pulmonary Failure, End Stage Liver Disease, Morbid Obesity, Recalcitrant Epilepsy Requiring Surgery, Healthy Subjects
In brief
Levels of tocotrienol in human tissues following supplementation is not currently known. The objective of this present study is to determine the levels of this form of vitamin E in the human tissues such as skin, heart, lung, liver, adipose tissue, Brain and cerebrospinal fluid (CSF) following oral supplementation
Key facts
- Study ID
- NCT00678834
- Run by
- Chandan K Sen
- People needed
- 80
- Starts
- 2006-03-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2014-09-16
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- The Ohio State University — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.